Do CASR loss-of-function variants increase susceptibility to pancreatitis?

The calcium-sensing receptor (CASR) plays a specialized role in maintaining pancreatic health by regulating the fluid and electrolyte balance within the pancreatic ducts. Research into loss-of-function variants of this receptor suggests they are a significant factor in pancreatitis susceptibility, particularly when occurring alongside other genetic or environmental risk factors.

Mechanistic explanations

CASR is expressed on the surface of pancreatic ductal cells, where it monitors extracellular calcium levels. When functioning normally, the receptor triggers an intracellular signaling cascade that activates intermediate-conductance calcium-activated potassium channels (IKCa) and the cystic fibrosis transmembrane conductance regulator (CFTR). This activation is essential for the secretion of bicarbonate (HCO₃⁻) and fluid into the pancreatic duct.

• Fluid and ion handling: Loss-of-function variants or pharmacological inhibition (e.g., using NPS-2143) significantly impair bicarbonate and fluid output.
• Pathological outcome: Inadequate bicarbonate secretion prevents the neutralization of acidic chyme and allows for the precipitation of calcium and proteins. This leads to the formation of calcium carbonate "stones" and ductal obstruction, which are hallmark features of chronic and tropical calcific pancreatitis.

Clinical effectiveness and susceptibility

While the physiological role of CASR is well-established, its role as an independent risk factor for pancreatitis varies across clinical studies.

• Population variability: A US-based study (N=450 cases) found that CASR variants were significantly associated with chronic pancreatitis, especially in patients who also consumed alcohol or carried mutations in the SPINK1 gene.
• Contradictory evidence: Large-scale studies in European cohorts (German, French, and Hungarian populations) failed to find a significant independent risk associated with common CASR missense variants like rs1801725 (A986S) or rs1042636 (R990G).
• Polygenic risk: Current clinical evidence suggests that while common CASR variants may not be sufficient to cause disease on their own, rare loss-of-function variants likely contribute to a polygenic risk profile. These variants may act synergistically with other mutations in the ductal pathway to lower the threshold for pancreatic inflammation.

Bottom line

Loss-of-function CASR variants disrupt the pancreatic duct's ability to secrete bicarbonate and fluid, creating a biochemical environment prone to obstruction and injury. While common variants are not independent predictors of disease in all populations, they are plausible susceptibility factors when part of a broader genetic or environmental risk profile.